IMPACT BIOMEDICAL INC. (IBO)
IMPACT BIOMEDICAL INC. (IBO)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Loss from operations | NaN | NaN | NaN | -15,631 |
| Net loss from operations | -2,284 | 5,235 | -17,105 | NaN |
| Depreciation and amortization | 285 | 286 | 288 | 571 |
| Stock-based compensation | 1,440 | 8 | 1 | 4 |
| Issuance of shares for professional services rendered | NaN | 0 | 0 | 190 |
| Accrued interest on notes payable | NaN | 0 | 262 | 531 |
| Change in deferred tax liability | NaN | -2,580 | NaN | NaN |
| Change in fair value of note payable, related party | NaN | -3,822 | 268 | 12,942 |
| Impairment of inventory | NaN | 419 | NaN | NaN |
| Loss on disposal of fixed assets | NaN | -12 | NaN | NaN |
| Accounts receivable | -5 | -10 | 15 | -4 |
| Inventory | NaN | -3 | -1 | -3 |
| Prepaid expenses and other current assets | -47 | -63 | 35 | -98 |
| Accounts payable | 27 | 607 | 22 | -159 |
| Accrued expenses | 16 | -142 | 69 | 71 |
| Net cash used by operating activities | -464 | 99 | -613 | -1,376 |
| Payments received on notes receivable | NaN | 1 | 1 | 1 |
| Borrowings on notes receivable | 1 | NaN | NaN | NaN |
| Net cash (used) provided by investing activities | -1 | 1 | 1 | 1 |
| Borrowings from related party | 482 | 184 | NaN | NaN |
| Borrowings on note payable, related party | NaN | NaN | NaN | 0 |
| Payments to related party | NaN | 293 | NaN | NaN |
| Net provided by financing activities | 482 | -109 | NaN | 0 |
| Net increase (decrease) in cash | 17 | -9 | -612 | -1,375 |
| Cash and cash equivalents at beginning of period | 3 | 12 | 1,999 | NaN |
| Cash and cash equivalents at end of period | 20 | 3 | 12 | NaN |